Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Cantor Fitzgerald
Argus Health
Teva
Covington

Generated: March 22, 2019

DrugPatentWatch Database Preview

PLENDIL Drug Profile

« Back to Dashboard

When do Plendil patents expire, and what generic alternatives are available?

Plendil is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in PLENDIL is felodipine. There are seventeen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the felodipine profile page.

Drug patent expirations by year for PLENDIL
Pharmacology for PLENDIL
Medical Subject Heading (MeSH) Categories for PLENDIL
Synonyms for PLENDIL
( inverted exclamation markA)-Felodipine
(.+/-.) Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
(.+/-.)-Felodipine
(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
(+/-) ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
105618-03-9
119945-59-4
2,6-dimethyl-1,4-dihydropyridine-
3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-
3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate
3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate #
3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-, ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-,ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester, (+-)-
3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-,ethyl methyl ester, (+-)-
4-(2,3-dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester
4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO- 2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLIC ACID ETHYL METHYL ESTER
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid ethyl methyl ester
4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester
5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
509F763
72509-76-3
72509-76-3 pound>>86189-69-7
86189-69-7
AB0014113
AB2000349
AC-2124
AC-24403
AC1L1FP2
AC1Q32PZ
AE-641/11429675
Agon
AGON SR
AK543880
AKOS015891545
AN-14248
AN-35618
ANW-42236
BC203911
BCP02192
BCP9000680
BDBM189379
BIDD:GT0733
BPBio1_000678
BRD-A30815329-001-03-0
BRN 4331472
BSPBio_000616
C18H19Cl2NO4
CAS-72509-76-3
CCG-204599
CGH-869
CHEBI:585948
CHEMBL1480
CHEMBL3196476
CPD002529504
CS-2348
CTK8B3303
D00319
DB01023
dl-Felodipine
DSSTox_CID_3042
DSSTox_GSID_23042
DSSTox_RID_76848
DTXSID4023042
EN300-70726
Ethyl methyl (4RS)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
EU-0100508
F 9677
F0814
Feloday
Felodipina
Felodipina [INN-Spanish]
felodipine
Felodipine (dl form)
Felodipine (JAN/USP/INN)
Felodipine (Plendil)
Felodipine [USAN:BAN:INN]
Felodipine [USAN:INN:BAN]
Felodipine [USAN:USP:INN:BAN]
Felodipine, European Pharmacopoeia (EP) Reference Standard
Felodipine, solid
Felodipine, United States Pharmacopeia (USP) Reference Standard
Felodipine,(S)
Felodipinum
Felodipinum [INN-Latin]
Felodur ER
Felogard
Flodil
FT-0626393
FT-0660933
GTPL4190
H 154-82
H 154/82
H-154/82
HMS1569O18
HMS2089J05
HMS2096O18
HMS2232D24
HMS3259F12
HMS3261F17
HMS3651O21
HMS3713O18
HY-B0309
Hydac
I14-9560
K235
KB-51851
KS-000001QR
KS-1264
Logimax
Lopac0_000508
LP00508
LS-131202
MCULE-8253440089
MFCD00868316
MLS000069629
MLS001077361
MLS001333735
MLS002153409
MLS002153832
MLS003876820
Modip
MolPort-002-801-136
Munobal
Munobal Retard
NC00721
NCGC00015455-03
NCGC00015455-04
NCGC00015455-05
NCGC00015455-06
NCGC00015455-07
NCGC00015455-08
NCGC00015455-10
NCGC00024087-02
NCGC00093906-01
NCGC00093906-02
NCGC00261193-01
NSC-760343
NSC760343
O5-ethyl O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Opera_ID_1873
Penedil
Perfudal
Pharmakon1600-01505887
Plandil
Plendil (TN)
Plendil Depottab
Plendil ER
Plendil Retard
Preslow
Prestwick_797
Prestwick0_000478
Prestwick1_000478
Prestwick2_000478
Prestwick3_000478
Prevex
PubChem15919
Renedil
Renedil;Feloday;Plendil
RZTAMFZIAATZDJ-UHFFFAOYSA-N
S-8162
s1885
SAM002589971
SC-12116
SCHEMBL13460298
SCHEMBL26398
SMR000058204
SMR002529504
SPBio_002555
Splendil
SR-01000075890
SR-01000075890-1
SR-01000075890-4
SW219299-1
Tox21_110155
Tox21_110155_1
Tox21_500508
Z239864852

US Patents and Regulatory Information for PLENDIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-004 Sep 22, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-001 Jul 25, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for PLENDIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-004 Sep 22, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
UBS
Cantor Fitzgerald
Julphar
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.